CLIA Watmind M2 and M5 portable analyzers
Languages: English
: pll_5ed8d924cf480
Sectors: Clinic
Areas: Biochemistry, Emergencies, Laboratory, Medical consultation, Microbiology, Pediatrics
Product lines: Point of Care
Watmind’s M2 and M5 CLIA analyzers are the world’s first CLIA-based portable diagnostic solution for COVID-19. It uses the reference method of magnetic separation by enzymatic chemiluminescence. It enables quantitative detection of IgM/IgG or total antibodies to COVID-19.
These portable analyzers reduce the response time, minimize the risk of transmission by detecting infection in the window period and increase the detection of positive cases. In addition, D-Dimer, cardiac markers and Procalcitonin can be tested.
Product features:
-
Compact design (min.4.5Kg) and maintenance-free
-
Integrated thermostat for reactions at 37ºC
-
Monotest (IgM or IgG) or multitest (IgA, IgM, IgE, IgD, IgG) sensor card
-
High sensitivity and specificity quantitative measure
-
Ideal for seroprevalence study or for PCR monitoring – / +
-
Quick results, only 15 minutes
-
Chemiluminescence-based method, immunoassay reference method
-
Other available tests: cardiac markers, Dimero D and PCT
-
Wide connectivity via GPS, 4G, WIFI, Bluethooth, iCloud

Technical specifications
Sample Type | Whole blood / peripheral blood / plasma / serum |
Sample volume | 5-50μl |
Test time | 10-15min/test |
Available tests | NT-proBNP, Toponin I, Myo, CK-MB, D-Dimer, PCT, SARS-CoV-2Ab/lgG/lgM |
Storage temperature | -20°C a+45°C |
Power Supply | AC 100V-240V50/60Hz |
Energy consumption | 300VA |
Dimensions | 267,5x180x220mm |
Weight | 4,5kg |
Procedure

Test menu

Microfluidic Chips

Watmind focuses on the application of high-tech, accurate and easy-to-operate chemiluminescence point-of-care diagnostic solutions for chemiluminescence and public health service and care.
Request information.
We advise you on the purchase and maintenance.
